Jump to content

Recommended Posts

  • Moderator
Posted

What is the difference between addiction and physical dependence?

 

There’s a lot of confusion about “addiction” and “dependence” among doctors and the general public. Addiction and physical dependence are not the same thing. Addiction has a behavioral component to it, while physical dependence is associated with physical effects, like tolerance or withdrawal symptoms.

 

In the FDA’s 2019 Draft Guidance Document addiction is defined as “a cluster of behavioural, cognitive, and physiological phenomena that may include a strong desire to take the drug, difficulties in controlling drug use, continuing drug use despite harmful consequences, giving a higher priority to drug use than other activities and obligations, and possible tolerance or physical dependence.” On the other hand, physical dependence “is a state that develops as a result of physiological adaptation in response to repeated drug use, manifested by withdrawal signs and symptoms after abrupt discontinuation or a significant dose reduction of a drug.” Therefore, “physical dependence is not synonymous with addiction; a patient may be physically dependent on a drug without having an addiction to the drug” (FDA, 2019).

 

Why does it matter?

 

This distinction is important, since inaccurate labeling may result in inappropriate or harmful treatment, as well as stigma and potential feelings of shame, guilt and fear. When we change our language, we increase awareness, break down stereotypes and reduce stigma and negative biases associated with use of, and discontinuation from, psychiatric medications.

 

If you have been taking any psychiatric drug, including benzodiazepines and sleep drugs, for more than a few months, your body has likely adapted to it and become physically dependent upon its consistent presence in your body (this process also leads to tolerance or loss of drug effect, which may not have any symptoms). The cardinal sign of physical dependence is the emergence of withdrawal symptoms when you reduce or stop the drug (O’Brien, 2018).

 

FDA. (2019). Drug Abuse and Dependence Section of Labeling for Human Prescription Drug and Biological Products—Content and Format Guidance for Industry. https://www.fda.gov/media/128443/download

 

O’Brien, C. P. (2018). Chapter 24: Drug Use Disorders and Addiction. In Brunton, Hilal-Dandan, & Knollmann (Eds.), Goodman & Gilman’s The pharmacological basis of therapeutics. (13th ed.). https://accessmedicine.mhmedical.com/content.aspx?bookid=2189&sectionid=170270255

 

2003-2009 on and off various SSRI's for short periods

2010-2011 Ativan

2013-2021 ativan 1-1.5mg 10-12x/month

2016 - Effexor 75mg, short-term

2021 Mar -Jun Buspar ADR at high dose, tapered 3 months

Oct 22/21 - Direct switch ativan to clonazepam (don't do this)

Tapered clonaz Oct/21 - Apr/23  - 0mg!

 

"Believe that your tragedies, your losses, your sorrows, your hurt, happened for you, not to you. And I bless the thing that broke you down and cracked you open, because the world needs you open" - Rebecca Campbell

 

*** Disclaimer: Please note, suggestions/comments are based on personal experiences. This is not medical advice. Please consult a knowledgeable practitioner to discuss decisions regarding your medical care *** 

 

                                                             *** Please do not send me PM's ***

  • Administrator
Posted

A helpful post , @LotusRising

 

Thanks for making the distinction between the two terms clear for me.

Please don't send me PMs. I am not a doctor. My comments are based on my personal experience with ADs and tapering. Consult your doctor about your own medical decisions.

Start of taper: Jan ’22 Vortioxetine 15mg

End year 1: 4.5mg

End year 2: 2.38mg

End year 3: 1.16mg

Year 4: The brassmonkey slide continues...

×
×
  • Create New...

Important Information

Terms of Use Privacy Policy